Johnson & Johnson reports $94.19 billion revenue for fiscal year ended December 28, 2025, up 6%
Johnson & Johnson reported revenue of $94.19 billion for the year ended December 28, 2025, an increase of 6% from the previous year ($88.82 billion).
For the same period it posted net income of $26.8 billion, up 90.6%, or $11.03 per diluted share (5.79 a year earlier).
That is a net margin of 28.5%.
On Sanad's AAOIFI Standard 21 screen, Johnson & Johnson is currently compliant: interest-bearing debt is 6.7% of market capitalisation (limit 30%), and impure income is 1.1% of revenue (limit 5%).
Is Johnson & Johnson halal?
See the full AAOIFI screening of Johnson & Johnson
See the full AAOIFI screening of Johnson & Johnson
Source: 10-K filed with the U.S. Securities and Exchange Commission on February 11, 2026. View the filing. Figures are as reported in the filing. This is information, not investment advice.